Enhanced resistance of adriamycin-treated MCR-5 lung fibroblasts by increased intracellular glutathione peroxidase and extracellular antioxidants

Biochemical and Molecular Medicine

Volumn 62, Issue 1, 1997, Pages 36-41

  Vanella, Angelo ^a   Campisi, Agata ^a   Di Giacomo, Claudia ^a   Sorrenti, Valeria ^a   Vanella, Giuseppe ^a   Acquaviva, Rosaria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; DIMETHYL SULFOXIDE; DOXORUBICIN; GLUTATHIONE PEROXIDASE; IRON CHELATE; MEMBRANE LIPID; SUPEROXIDE DISMUTASE;

ARTICLE; CARDIOTOXICITY; CELL MEMBRANE RESISTANCE; CELL PROTECTION; COMPLEX FORMATION; DETOXIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; INFLAMMATION; LIPID PEROXIDATION; LUNG FIBROBLAST;

EID: 0031259573     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2612     Document Type: Article

References (50)

1. 1. Blum RH, Carter SK. Adriamycin - A new anticancer drug with significant clinical activity. Ann Intern Med 80:249-259, 1974.
2. 2. DiMarco A, Arcamone F, Zunino F. Mechanism and action of antimicrobial and antitumor agents. In The Antibiotics (Corcoran JW, Hahn FE, Eds.), Berlin: Springer-Verlag, 1975, Vol. 3, pp 101-128.
3. 3. Gianni L, Corden BJ, Myers CE. The biochemical basis of anthracycline toxicity and anti-tumor activity. Rev Biochem Toxicol 5:1-82, 1983.
4. 4. Buja LM, Ferrans VJ, Mayer RJ, Robert WC, Henderson ES. Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32:771-778, 1973.
5. 5. Lenaz L, Page JA. Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat Rev 3:111-120, 1976.
6. 6. Olson HM, Capen CC. Subacute cardiotoxicity of ADM in the rat; biochemical and ultrastructural investigations. Lab Invest 37:386-394, 1977.
7. 7. Rudolph R, Stein RS, Pattilo RA. Skin ulcers due to adriamycin. Cancer 38:1087-1093, 1976.
8. 8. Reilly JJ, Neifeld JP, Rosenberg SD. Clinical course and management of accidental adriamycin extravasation. Cancer 40:2053-2056, 1977.
9. 9. Rudolph R, Susuki M, Luce JK. Experimental skin necrosis produced by adriamycin. Cancer Treat Rep 63:529-537, 1979.
10. 10. Doroshow JH, Locker GY, Myers CE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J Clin Invest 65:128-135, 1980.
11. 11. Handa K, Sato S. Generation of free radicals of quinone group-containing anticancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation. Gann 66:43-47, 1974.
12. 12. Bachur NR, Gordon SL, Gee MV. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. Mol Pharmacol 13:901-910, 1977.
13. 13. Thayer WS. Adriamycin stimulated Superoxide formation in sub-mitochondrial particles. Chem Biol Interact 19:265-278, 1977.
14. 14. Mimnaugh EG, Trush MA, Bhatnagar M, Gram TE. Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin. Biochem Pharmacol 34:847-856, 1985.
15. 15. Thornalley PJ, Dodd JF. Free radical production from normal and adriamycin-treated rat cardiac sarcosomes. Biochem Pharmacol 34:669-676, 1985.
16. 16. Gianni L, Zweier JL, Levy A, Myers CE. Characterization of the cycle of iron-mediated electron transfer from adriamycin to molecular oxygen. J Biol Chem 260:6820-6826, 1985.
17. 450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 76:954-957, 1979.
18. 18. Davies KJA, Doroshow JH. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 261:3060-3067, 1986.
19. 19. Winterborn C. Evidence for the production of hydroxyl radicals from the adriamycin semiquinone and hydrogen peroxide. FEBS Lett 136:89-94, 1981.
20. 20. Kalyanaraman B, Morehouse KM, Mason RP. An electron paramagnetic resonance study of the interactions between the adriamycin semiquinone, hydrogen peroxide, iron-chelators, and radical scavengers. Arch Biochem Biophys 286:164-171, 1991.
21. 21. Kappus H, Muirawan H, Scheulen ME. In vivo studies on adriamycin induced lipid peroxidation and effects of ferrous ions. In The Mechanism of Toxicity and Hazard Evaluation (Holmstedt B, Lauwerys R, Mericer M, Roberfroid M, Eds.). Holland: Elsevier/North, 1980, pp 635-642.
22. 22. Sugioka K, Nakano H, Noguchi T, Tsuchiya J, Nakauo M. Decompositions of unsaturated phospholipid by iron-ADP-adriamycin coordination complex. Biochem Biophys Res Commun 100:1251-1256, 1981.
23. 23. Myers CE, Gianni L, Simone CB, Klecker R, Greene R. Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin iron complex. Biochemistry 21:1707-1712, 1982.
24. 3+-doxorubicin complex undergoing self-reduction by its α-ketol group. Biochem Cell Biol 68:1331-1336, 1990.
25. 450 reductase promotes hydroxyl radical production by the iron complex of ADR-925, the hydrolysis product of ICRF-187 (dexrazoxane). Free Radic Res 22:319-325, 1995.
26. 26. Tappel A. Lipid peroxidation damage to cell components. Fed Proc 32:1870-1874, 1973.
27. 27. Freeman BA, Crapo JD. Biology of disease free radicals and tissue injury. Lab Invest 47:412-426, 1982.
28. 28. Myers L. Free radicals damage of nucleic acids and their components by ionizing radiation. Fed Proc 32:1882-1894, 1973.
29. 29. Myers CE, McGuire W, Young R. Adriamycin: Amelioration of toxicity by α-tocopherol. Cancer Treat Rep 60:961-962, 1976.
30. 30. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response. Science 197:165-169, 1977.
31. 31. Sonneveld P. Effect of α-tocopherol on the cardiotoxicity of adriamycin in the rat. Cancer Treat Rep 62:1033-1035, 1978.
32. 32. Mimnaugh EG, Siddick ZH, Drew R, Sikic B, Gram T. The effects of alfa-tocopherol on the toxicity, disposition and metabolism of adriamycin in mice. Toxicol Appl Pharmacol 49:119-126, 1979.
33. 33. Wang YM, Madanat FF, Kimball JC, Gleiser CA, Ali MK, Kaufman MW, Van Eys J. Effect of vitamin E against adriamycin-induced toxicity in rabbits. Cancer Res 40:1022-1027, 1980.
34. 34. Doroshow JH, Locker CY, Ifrim J, Myers CE. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetyl cysteine. J Clin Invest 68:1053-1064, 1981.
35. 35. Svingen BA, Powis G, Appel PL, Scott M. Protection against adriamycin-induced skin necrosis in the rat by dimethylsulfoxide and alpha-tocopherol. Cancer Res 41:3395-3399, 1981.
36. 36. Desal MH, Teres D. Prevention of doxorubicin-induced skin ulcers in the rat and pig with dimethylsuphoxide (DMSO). Cancer Treat Rep 66:1371-1374, 1982.
37. 37. Stadtman TC. Selenium-dependent enzymes. Annu Rev Biochem 49:93-110, 1980.
38. 38. Tappel AL. Measurement of and protection from in vivo lipid peroxidation. In The Free Radical in Biology (Pryor WA, Ed.). New York: Academic Press, 1980, pp 1-50.
39. 39. Housset B, Junod AF. Effects of culture conditions and hyperoxia on antioxidant enzymes in pig pulmonary artery and aortic endotelium. Biochem Biophys Acta 716:283-289, 1982.
40. 40. Hornsby PJ, Pearson DW, Autor AP, Aldern KA, Harris SE. Selenium deficiency in cultured adrenocortical cells: Restoration of glutathione peroxidase and resistance to hydroperoxides on addition of selenium. J Cell Physiol 38:123-133, 1985.
41. 41. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169, 1967.
42. 42. Lowry OH, Rosenbrough NJ, Farr AJ, Randall RG. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951.
43. 43. Henry RJ, Chiamori H, Coolub OJ, Berkman S. Revised spectrophotometric method for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase and lactic acid dehydrogenase. Am J Clin Pathol 34:381-398, 1960.
44. 44. Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Its role in degradation of hyaluronic acid by a superoxide-generating system. FEBS Lett 96:238-242, 1978.
45. 45. Forstrom JW, Zakowski JJ, Tappel AL. Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteine. Biochemistry 17:2639-2644, 1978.
46. 46. Zakowski JJ, Forstrom JW, Condell RA, Tappel AL. Attachment of selenocysteine in the catalytic site of glutathione peroxidase. Biochem Biophys Res Commun 84:248-253, 1978.
47. 47. Omaye ST, Reddy KA, Cross CE. Enhanced lung toxicity of paraquat in selenium-deficient rats. Toxicol Appl Pharmacol 43:237-247, 1978.
48. 48. Dershwitz M, Novak RF. Lack of inhibition of glutathione reductase by anthracycline antibiotics. Biochem Pharmacol 30:676-677, 1981.
49. 49. Gutteridge JMC, Richmond R, Halliwell B. Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem J 184:469-472, 1979.
50. 50. Klein SM, Cohen G, Coderbaum AI. Production of formaldehyde during metabolism of dimethylsufoxide by hydroxyl radical generating systems. Biochemistry 20:6006-6012, 1981.